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The pedunculopontine nucleus, a component of the reticular formation, is topographically organized in animal models and
implicated in locomotor control. In Parkinson’s disease, pedunculopontine nucleus stimulation is an emerging treatment for gait
freezing. Local ﬁeld potentials recorded from pedunculopontine nucleus electrodes in such patients have demonstrated oscilla-
tions in the alpha and beta frequency bands, reactive to self-paced movement. Whether these oscillations are topographically
organized or relevant to locomotion is unknown. Here, we recorded local ﬁeld potentials from the pedunculopontine nucleus in
parkinsonian patients during rest and unconstrained walking. Relative gait speed was assessed with trunk accelerometry. Peaks
of alpha power were present at rest and during gait, when they correlated with gait speed. Gait freezing was associated with
attenuation of alpha activity. Beta peaks were less consistently observed across rest and gait, and did not correlate with gait
speed. Alpha power was maximal in the caudal pedunculopontine nucleus region and beta power was maximal rostrally. These
results indicate a topographic distribution of neuronal activity in the pedunculopontine nucleus region and concur with animal
data suggesting that the caudal subregion has particular relevance to gait. Alpha synchronization, proposed to suppress ‘task
irrelevant’ distraction, has previously been demonstrated to correlate with performance of cognitive tasks. Here, we demonstrate
a correlation between alpha oscillations and improved gait performance. The results raise the possibility that stimulation of
caudal and rostral pedunculopontine nucleus regions may differ in their clinical effects.
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Abbreviations: FzCz = frontal zero central zero; PPN = pedunculopontine nucleus; UPDRS = Uniﬁed Parkinson’s Disease Rating Scale
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The pedunculopontine nucleus (PPN) is a reticular collection of
neurons, located at the junction of midbrain and pons
(Jacobsohn, 1911; Olszewski and Baxter, 1954; Alam et al.,
2011) The PPN, at least in animal models, appears to be topo-
graphically organized, with -aminobutyric acid expressing neu-
rons predominating rostrally and cholinergic and glutamatergic
neurons caudally (Martinez-Gonzalez et al., 2011). In
Parkinson’s disease, cholinergic PPN neurons degenerate and this
cell loss has been associated with gait dysfunction (Hirsch et al.,
1987; Zweig et al., 1989; Rinne et al., 2008; Karachi et al., 2010).
PPN neurons in Parkinson’s disease may also be disrupted through
their reciprocal connectivity with the basal ganglia (Breit et al.,
2001; Mena-Segovia et al., 2004). In patients with Parkinson’s
disease, deep brain stimulation of the PPN region at low frequen-
cies is an emerging treatment for postural instability and gait
freezing (Plaha and Gill, 2005; Ferraye et al., 2009; Moro et al.,
2010; Thevathasan et al., 2011a).
The control of locomotion likely involves coordination be-
tween spatially segregated nervous system regions in order
to modulate the rhythmic activity produced by spinal central
pattern generators (Grillner et al., 2008). Synchronized oscillatory
neuronal activity is proposed to bind together such neuronal
assemblies and enhance information representation—whilst also
suppressing task irrelevant or competing processes (Fries, 2005;
Schoffelen et al., 2005; Jensen and Mazaheri, 2010). Local ﬁeld
potential recordings from deep brain stimulation electrodes im-
planted in the PPN in parkinsonian patients have variably been
reported to demonstrate alpha or beta band oscillations, reactive
to self-paced movement (Androulidakis et al., 2008a, b; Tsang
et al., 2010). Whether these different oscillatory patterns conform
to any topographic distribution or are relevant to locomotion is
unknown.
In this study, we assessed local ﬁeld potentials from parkinso-
nian patients implanted with PPN electrodes and assessed the spa-
tial pattern of oscillatory activity in the region and its relationship
to the performance of gait.
Materials and methods
Subjects and clinical assessments
Seven patients with Parkinson’s disease implanted with deep brain
stimulation electrodes in the PPN region were assessed (Table 1).
Following their initial implantation, electrodes were attached to special
extension cables ‘externalized’ through the scalp to permit connection
with recording equipment. Final implantation of deep brain stimulation
hardware was therefore deferred for the period of ‘externalization’
(3–7 days). Eleven PPN electrodes were recorded from the seven pa-
tients. Patients were recruited from hospitals in Oxford and London,
UK. Local ethics committee approval was obtained from both centres
and participants gave written informed consent. Reaction time results
from one of the patients have been reported previously (Thevathasan
et al., 2010, 2011b).
The indication for PPN stimulation was severe gait freezing and
postural instability, persisting even ‘ON medication’ and either causing
frequent falls or precluding walking. In Parkinson’s disease, gait freez-
ing and postural instability become more frequent and less responsive
to medication with disease progression (Giladi et al., 2001; Bloem
et al., 2004). The overall prevalence of gait freezing and postural
instability in Parkinson’s disease is 50% (Macht et al., 2007).
However, severe medication resistant gait freezing and postural
instability as the predominant issue is unusual in Parkinson’s disease
and raises the question of atypical pathologies (Factor, 2008; Jankovic,
2008). As there is no deﬁnitive test in life, we stress that the diagnosis
of Parkinson’s disease in our series is presumptive.
Preoperative assessments included the motor subsection (part III) of
the Uniﬁed Parkinson’s Disease Rating Scale (UPDRS; score/108). OFF
medication assessments occurred after overnight withdrawal (412h)
of dopaminergic therapy. UPDRS was segmented into items 27–30
(IT27/30, score/16) assessing posture, gait and balance and residual
items 1–26 (R-UPDRS, score/92) assessing bradykinesia, rigidity and
tremor. Patients treated in Oxford also prospectively completed the
Gait and Falls Questionnaire (score/64) which assesses Parkinsonian
gait disturbance including gait freezing, festination and falls
(Giladi et al., 2000). The Freezing of Gait Questionnaire (score/24)
and Falls Question (score/4) are components of the Gait and Falls
questionnaire (Giladi et al., 2000, 2009). For all motor scales, higher
scores indicate worse function. The London patient was assessed with
Table 1 Clinical details of the study participants
Patient Age
(years)
Parkinson’s
disease
duration
(years)
UPDRS
III OFF/ON
medication
(score/108)
R-UPDRS
OFF/ON
medication
(score/92)
IT27-30
OFF/ON
medication
(score/16)
GFQ
(score/64)
FOGQ
(score/24)
FallsQ
(score/4)
L-dopa dose
equivalent
(mg/day)
Supportive for
UK Brain Bank
criteria
a
1 55 14 35/24 28/18 7/6 55 22 4 1600 A, P
2 76 16 34/25 25/16 9/9 38 20 1 600 D, A, P
3 55 25 33/22 27/17 6/5 36 15 3 300 D, A, P
4 68 9 40/26 29/18 11/8 49 24 2 1650 A, P
5 70 20 35/22 29/17 6/5 36 13 3 900 D, A, T, P
6 71 20 37/19 27/14 10/5 NA NA 2 1450 D, A, T, P
7 54 20 53/19 47/14 6/5 38 14 4 800 D, A, T, P
All patients were operated in Oxford except Patient 6 (London). All patients were male. FOGQ = Freezing of Gait Questionnaire (score/24); Falls Q = Falls Questionnaire
(score/4); GFQ = Gait and Falls questionnaire; NA = not assessed. For all motor scales, higher scores indicate worse function. A = asymmetry persistent; D = dyskinesias;
P = progressive disease course; T = tremor at rest.
a Additional to disease duration and L-dopa response as documented elsewhere in the table.
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Techniques to target and implant electrodes in the PPN have been
described previously (Pereira et al., 2008; Zrinzo et al., 2008; Foltynie
and Hariz, 2010). In two early studies of stimulation in this vicinity,
electrodes appeared to be placed lateral to the lemniscal system—in
the peripeduncular nucleus rather than the PPN (Mazzone et al., 2005;
Stefani et al., 2007; Yelnik, 2007; Zrinzo and Hariz, 2007; Zrinzo
et al., 2007). In the current study, the PPN was targeted medial to
the lemniscal system and lateral to the superior cerebellar peduncle
and its decussation. Electrodes (Medtronic) were conﬁgured with
four active contacts each spanning 1.5mm. Electrodes in six patients
were model 3389 (0.5mm spacing between contacts) and in one pa-
tient were model 3387 (1.5mm spacing between contacts). Contact
coordinates were assessed on postoperative MRI or postoperative
CT fused with preoperative MRI and transformed onto Montreal
Neurological Institute (MNI) space using the fMRIB Software Library
(Smith et al., 2004). Coordinates were calculated in millimetres from
midline (laterality), ventrodorsal distance (d) from ﬂoor of the fourth
ventricle and rostrocaudal distance (h) from a pontomesencephalic line
connecting the pontomesencephalic junction to the caudal end of the
inferior colliculi, as described previously (Ferraye et al., 2009).
Electrode locations are summarized in Fig. 1A.
Experiments and recordings
Experiments took place 2–6 days after electrode implantation.
Assessments were performed ‘OFF medication’, after overnight with-
drawal of dopaminergic medication, to limit variance from ﬂuctuating
dopaminergic state and to maximize gait disturbance.
There were two conditions: rest and gait. For rest recordings, pa-
tients sat comfortably with eyes open for 2–3min. For gait recordings,
patients walked at their preferred speed along an unobstructed path
10m long, 10–30 times (depending on speed and fatigue).
Local ﬁeld potentials were recorded in bipolar conﬁguration from
consecutive contacts (01, 12 and 23) of each electrode (Fig. 2A).
Local ﬁeld potentials were band-pass ﬁltered between 0.5 and
500Hz. Single channel EEG was recorded from FzCz (frontal zero cen-
tral zero). In Patients 1–6, a triaxial accelerometer (TMSI) was ﬁrmly
ﬁxed with tape over the spinous processes at the upper thoracic level
to record trunk acceleration. A portable battery powered ampliﬁer
(Porti ampliﬁer, TMSI) was attached with a waist belt. Data were
sampled at 2048Hz and recorded on a laptop (Porti32 software) via
a long ﬁbre-optic cable.
Data analysis and parameters
Data were analysed in Spike 2 (Cambridge electronic design) using
routines therein. Unless stated otherwise, all frequency spectral ana-
lyses employed non-overlapping blocks of 4s duration that afforded a
resolution of 0.25Hz (fast Fourier transform, Hanning window). The
mean (SEM) duration of recordings at rest was 222  38s and for
gait was 253  68 s.
Gait assessment with trunk accelerometer
Three dimensional trunk accelerometry is a validated method to assess
spatiotemporal parameters of gait in healthy subjects and patients with
Parkinson’s disease (Dijkstra et al., 2008; Lord et al., 2008; Senden
et al., 2009). Acceleration in the anteroposterior plane is predicted by
an inverted pendulum model (MacKinnon and Winter, 1993). During
single support after mid stance, forward acceleration increases as the
body falls forwards and downwards (Zijlstra, 2004). Acceleration peaks
at the point of foot contact after which there is sharp deceleration and
ultimately reversal of body motion to upwards and backwards along
with contralateral foot elevation. Thus the biggest transients in antero-
posterior trunk acceleration oscillate in time with stepping.
Gait speed can be reliably estimated from the amplitudes of antero-
posterior acceleration related to stepping (Cappozzo, 1982;
Moe-Nilssen, 1998; Zijlstra and Hof, 2003; Zijlstra, 2004). The pre-
dominant frequency of stepping (cadence) within 4 s blocks is identi-
ﬁable as the peak in spectral power over 1–3Hz, corresponding to the
‘locomotor frequency band’ (Ichinoseki-Sekine et al., 2006). This fre-
quency band captures the typical ranges of cadences reported during
unconstrained walking in healthy and parkinsonian subjects
(MacDougall and Moore, 2005; Sofuwa et al., 2005; Mirelman
et al., 2011). Relative gait speed can be derived from the power of
the spectral peaks indicating cadence, as gait speed has a quadratic
relationship with amplitudes of anteroposterior acceleration
(Moe-Nilssen, 1998). The estimation of relative gait speed was con-
sidered sufﬁcient for our purposes as we sought correlations between
this parameter and local ﬁeld potential activity within subjects.
Estimation of absolute gait speed requires further assumptions, such
as leg length helping predict step length. Such accelerometer based
methods have been validated in both healthy subjects and parkinso-
nian patients and are substantially more accurate than the threshold
crossing algorithms employed by pedometers (Ichinoseki-Sekine et al.,
2006; Dijkstra et al., 2008; Lord et al., 2008; Speelman et al., 2011).
In accordance with the above, relative gait speed was computed as
follows. The accelerometer channel detecting acceleration in the an-
terior–posterior axis was selected for analysis. Periods marked during
experiments as other than unconstrained walking (e.g. turning, stand-
ing) were spliced out. Cadence was identiﬁed for every non-
overlapping 4s block as the peak frequency in acceleration over
1–3Hz. In each patient, depending on the variability of cadence, a
span of 4–6 spectral bins (1.0–1.5Hz) was identiﬁed to cover the
predominant spectrum of cadences over all blocks. Power within this
individualized frequency band computed for every 4 s block of walking
yielded the relative gait speed.
Figure 1 Localization of electrodes and contact locations
represented in MNI space (sagittal view). The colouring of
electrode tips identiﬁes the electrodes of individual patients.
PM = pontomesencephalic line connecting the pontomesence-
phalic junction to the caudal end of the inferior colliculi.
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Local ﬁeld potentials during rest and gait
Local ﬁeld potential frequency spectra from each bipolar contact pair
(01, 12 and 23) were derived for the periods of sitting and walking
(Fig. 2B and C). The frequency and power of spectral peaks was as-
sessed. Peaks were identiﬁed as local elevations in power spanning at
least ﬁve contiguous 0.25Hz bins with a minimum rise of two and fall
of three adjacent bins [the asymmetry in criteria necessary given the
background (1/f) decrease of local ﬁeld potential power with fre-
quency, f]. Where several peaks occurred within a broader based
power elevation, the peak frequency was deﬁned as the midpoint of
this activity. Spectral peaks were sought over 7–100Hz and identiﬁed
in the alpha (deﬁned here as 7–12Hz) and beta (13–30Hz) bands.
Where more than one discrete peak occurred within a given frequency
band, the most prominent peak was selected for analyses. Power in
each spectral peak was calculated as the sum of power around the
centre of the peak, spanning 4Hz for alpha and 2Hz for beta (the
differing ranges reﬂecting the relative sizes and skirt-widths of these
peaks). For rest recordings, log power of local ﬁeld potential peaks was
used in analyses. To limit the effects of any movement artefact, local
ﬁeld potential power during walking was normalized (as was rest local
ﬁeld potential power when compared with walking local ﬁeld potential
power). Alpha power was expressed as per cent of total power over
5–40Hz and beta power expressed as per cent of total power over
15–40Hz. The more restricted range for beta aimed to exclude recip-
rocal effects from higher amplitude alpha activity, whereby the gen-
erally larger changes in the alpha band might have obscured changes
in the beta band. This approach was considered reasonable as no
direct comparison was made between frequency bands.
Localization of local ﬁeld potential power
The centre of each bipolar recording site was calculated from the co-
ordinates derived for electrode contacts (described above). For rest
recordings, the mean un-normalized local ﬁeld potential spectral log
power in the alpha band could be assessed over 4-mm subregions
spanning the entire rostrocaudal extent of recordings. For recordings
during gait (including all beta band analyses, as fewer beta peaks
necessitated collapsing data at rest and during gait), the smaller gra-
dients afforded by normalizing local ﬁeld potential power meant that
power in spectral peaks was simply compared between sites below and
above a point 2mm below the pontomesencephalic line, used to
deﬁne the ‘caudal PPN’ and ‘rostral PPN’ regions.
Coherence between local ﬁeld potential and
electroencephalography
Coherence was sought between local ﬁeld potentials and single chan-
nel EEG at FzCz (Fig. 2D). This was estimated using non-overlapping
data blocks of 1s, affording 1Hz resolution, using standard techniques
(Grosse et al., 2002). Peaks in coherence were sought at the
Figure 2 Example data from Patient 3, left PPN electrode at contact pair 01. (A) Raw local ﬁeld potential (LFP) during rest. (B) Local ﬁeld
potential autospectrum averaged over the period (127 s) of rest. Note peak at 9Hz (‘peak rest local ﬁeld potential’). (C) Autospectrum of
local ﬁeld potential averaged over the period of unconstrained walking. Note peak at 8Hz (‘peak gait local ﬁeld potential’). (D) Spectra of
coherence between the local ﬁeld potential and EEG (FzCz) during the period of walking. Horizontal line is the 95% conﬁdence limit. Note
the peak in coherence at 8–9Hz. (E) Peak alpha power (sum of normalized power over 6–10Hz) correlation with relative gait speed (rGS).
Linear regression line and its 95% conﬁdence limit are shown. (F) Cross frequency local ﬁeld potential (normalized) correlation with
relative gait speed. Dotted line is the raw correlation and continuous line is the 6-point (backwards) moving average. Note the peak
in correlation in the alpha band.
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pairs expressing the highest power at these peaks. Coherence was
considered relevant where there was signiﬁcant coherence spanning
at least two contiguous bins in a 4 or 2Hz band corresponding to the
local ﬁeld potential spectral peak in the alpha and beta bands,
respectively.
Correlation between local ﬁeld potential and relative
gait speed
Local ﬁeld potential power spectra from each bipolar contact pair were
derived from consecutive, non-overlapping 4s blocks during walking.
Cadence varied insufﬁciently to assess for correlations with local ﬁeld
potential. Correlations between the relative gait speed and local ﬁeld
potential were assessed as follows.
Spectral peak local ﬁeld potential correlation with relative
gait speed
Normalized local ﬁeld potential power at spectral peaks was assessed
(from the bipolar pair expressing the highest power in each electrode)
for each 4s block during walking and correlated with the relative gait
speed from corresponding sections (Fig. 2E).
Across frequency local ﬁeld potential correlation with
relative gait speed
Normalized local ﬁeld potential power across different frequencies was
correlated with relative gait speed yielding correlation spectra.
Thereby, the frequency of local ﬁeld potential that correlated most
strongly with the gait index could be identiﬁed (Fig. 2F). We could
therefore test the assumption that correlations were strongest at the
frequency of the peak in local ﬁeld potential power spectra.
Local ﬁeld potential power averaged to gait freezing
episodes
In Patient 6, discrete freezing episodes were sufﬁcient in number to
allow local ﬁeld potential activity to be averaged to the onset of gait
freezing. Freezing onset was determined by thresholding the root
mean square of the anteroposterior accelerometer signal over
1.0–3.0Hz. Local ﬁeld potential power was derived from
non-overlapping data blocks of 1s, affording a 1Hz spectral reso-
lution. Power at the alpha peak and ﬂanking two spectral bins at
the contact pair expressing highest alpha power was aligned to freez-
ing onset according to change-point analysis, using commercial soft-
ware (Change-Point Analyser 2.0 shareware program, Taylor
Enterprises Inc., http://www.variation.com) and techniques described
previously (Cassidy et al., 2002). Change-point analysis iteratively uses
time varying cumulative sum charts and bootstrapping to detect
changes in time series (Taylor, 2000). For this analysis, cumulative
sum charts were determined by plotting the sequentially summed
deviation of each spectrum from the average determined for the
whole record (total of 11s). Ten thousand bootstraps were performed
and only changes with probabilities of 495% were highlighted.
Statistics
The Kolmogorov–Smirnov Test demonstrated that the distribution of
normalized peak local ﬁeld potential power and relative gait speed was
not different from the normal. Normalized local ﬁeld potential power
in speciﬁc frequency bands was compared between conditions and/or
recording sites using paired t-tests. Differences in normalized local ﬁeld
potential power across a range of frequencies were assessed with serial
t-tests performed for each frequency. Correlations (Pearson’s) were
sought between peak local ﬁeld potential frequencies across conditions
and between normalized local ﬁeld potential power and relative gait
speed. Level of signiﬁcance was P50.05.
Results
Gait assessment
Following electrode implantation and without stimulation, all pa-
tients experienced a reduction in gait freezing, which persisted up
to 6 weeks—a time course consistent with ‘stun effect’ (Koop
et al., 2006). Preoperatively, when ‘OFF medication’, every pa-
tient experienced frequent, long duration freezing. However, post-
operatively when ‘OFF medication’ during experiments, freezing in
ﬁve patients was infrequent and then typically brief (53s). In two
patients (who were both implanted unilaterally), freezing had im-
proved but remained clinically severe. In one of these patients
(Patient 6) discrete freezing episodes were identiﬁable while in
the other (Patient 2) freezing was almost continuous. Festination
was not observed during experiments. The mean cadence (SD)
across patients for every 4s block of walking was 1.81Hz
(0.28). Relative gait speed coefﬁcients of variation ranged
from 40 to 308% between patients, consistent with some
degree of gait disturbance, despite the stun effect. Cadence was
less variable, with coefﬁcients of variation ranging from 6 to 21%
between patients.
Local ﬁeld potentials and their
relationship to electroencephalography
and gait
Spectral analysis during rest and gait
A discrete peak in the alpha band was present in all electrode
recordings during rest and gait (Fig. 2B and C). A discrete peak
in the beta band was observed in 6/11 electrodes (5/7 patients).
Beta peaks occurred inconsistently across rest and gait, being pre-
sent across both conditions in only two electrodes. Gamma band
peaks were not identiﬁed in any recordings, at rest or during gait.
Alpha band activity
Activity during rest and gait
The frequencies of alpha peaks during rest (mean 8.2Hz, range
7–10Hz) and gait (mean 8.4Hz, range 7–10Hz) correlated
strongly (r=0.90, P50.001) across patients (Figs 2A–C
and 3A), suggesting that the peaks were homologous across the
two states. Alpha peaks were relatively focal to one bipolar con-
tact pair. Normalized peak alpha (SEM) power dropped in the
remaining two contact pairs by 15.6% (2.5) at rest and 14.2%
(2.8) during gait. Even so, these values likely underestimate
the gradient across contacts due to the normalization procedure.
At rest, where there was no potential contamination by movement
artefact, the un-normalized peak alpha (SEM) power dropped
in the remaining two contact pairs by 42.7% (9.0). In all but
one electrode, the normalized alpha power during rest and
gait was maximal at the same (7/11 electrodes) or an adjacent
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not signiﬁcantly differ between rest and gait.
Localization
Normalized alpha peak power during gait was signiﬁcantly greater
at caudal (deeper than 2mm below the pontomesencephalic junc-
tion) compared with rostral recording sites [t(31) = 4.183,
P50.001; Fig. 4A]. During rest, normalized alpha peak power
was also signiﬁcantly greater in caudal compared with rostral re-
cording sites [t(31) = 3.359, P50.001].
For rest recordings, which did not require normalization, we
were able to follow un-normalized log alpha peak power across
recording depth (Fig. 4B). The resting un-normalized log alpha
peak power was divided according to the depth of each recording
site into subregions spanning 4mm along a rostrocaudal axis. An
ANOVA revealed a signiﬁcant difference in log alpha peak power
across these subregions [F(4,28) = 7.873, P50.001) (Fig. 4B).
Resting un-normalized log alpha peak power was maximal in
the caudal PPN subregion between 2 and 6mm below the
pontomesencephalic junction, falling signiﬁcantly at rostral
subregions [2t o6mm versus 2 to +2mm, t(10) = 3.177,
P=0.010 and 2t o6mm versus +2 to +6mm t(8) = 4.793,
P=0.003] and caudal subregions [2t o6mm versus 6t o
10mm, t(14) = 2.845, P=0.013 and 2t o6mm versus
10 to 14mm t(11) = 2.667, P=0.022]. These sub-
regions along the rostrocaudal axis are represented in Fig. 4C
in standard MNI space. For Patient 3’s left electrode (used as
the individual example for local ﬁeld potentials in Fig. 2) the high-
est resting peak alpha power was at 2.5 and 4.2mm below the
pontomesencephalic line—reﬂecting ﬁndings from the grouped
analysis. For this patient, to give an example of the anatomy of
the region expressing highest alpha power, axial MRI slices across
this and ﬂanking regions are displayed in the Supplementary
material.
Coherence with EEG
In 7/11 electrodes, signiﬁcant local ﬁeld potential EEG coherence
spanning at least two consecutive 1Hz bins was observed within
the alpha peak range during rest and/or walking (Fig 2D).
Figure 3 (A) Relationship between the peak rest local ﬁeld potential (LFP) and peak gait local ﬁeld potential. The strong correlation
(r=0.90, P50.001) suggests that the two local ﬁeld potential peaks may be related. (B) Relationship between the peak rest local ﬁeld
potential and the frequency of the peak in the local ﬁeld potential–relative gait speed (rGS) correlation spectra. The strong correlation
(r=0.779, P=0.013) suggests that the peak rest local ﬁeld potential may be relevant to the performance of gait. (C) Group average
un-normalized local ﬁeld potential and relative gait speed correlation spectra demonstrating a peak in correlation in the alpha band. Dotted
line is the average correlation and continuous line is the 6-point (backwards) moving-average. (D) Group averaged normalized (across
5–40Hz) local ﬁeld potential and relative gait speed correlation spectra demonstrating persistence of the peak in correlation in the alpha
band. Dotted line is the average correlation and continuous line is the 6-point (backwards) moving-average. Correlations were Fisher
transformed prior to averaging in C and D.
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In eight of nine electrodes where local ﬁeld potential and trunk
acceleration were simultaneously recorded, normalized peak alpha
power correlated signiﬁcantly with the relative gait speed. In these
electrodes, the mean correlation was r=0.433, P50.01 (see
Fig. 2E for an example from a single electrode). Local ﬁeld poten-
tial relative gait speed correlation spectra in all electrodes revealed
that the correlation peaked in the alpha band (see Fig. 2F for an
example from a single electrode). The frequency of this peak
correlated strongly with the peak local ﬁeld potential during gait
(r=0.782, P=0.013) and peak local ﬁeld potential at rest
(r=0.779, P=0.013; Fig. 3B). When averaged across recordings,
spectra of the Fisher transformed correlations between local ﬁeld
potential power and relative gait speed demonstrated a discrete
positive peak in correlation at 7–10Hz, regardless of whether local
ﬁeld potential power was raw (Fig. 3C) or normalized (Fig. 3D).
Note that normalization inevitably induced a negative correlation
at frequencies below 7Hz.
Figure 4 (A) Normalized power (mean  SEM) of alpha peaks during gait and beta peaks during rest or gait grouped according to caudal
(deeper than 2mm below the pontomesencephalic junction) or rostral recording site. Alpha peak power was greater caudally and beta
power was greater rostrally. (B) Log alpha peak power at rest (mean  SEM) divided according to recording site depth into 4-mm
subregions (denoted on the x-axis in mm relative to the pontomesencephalic junction). Log alpha peak power is maximal in the 2t o
6mm region, falling signiﬁcantly at surrounding sites. *P50.05. In grey has been superimposed a plot of the variation in per cent
improvement in the Gait and Falls questionnaire (GFQ) postoperatively according to stimulation depth at most recent follow-up [depth
selected blinded to the local ﬁeld potential (LFP) data]. One data point was available from each subject (Table 2), with the exception of the
patient from London, where the Gait and Falls questionnaire was not assessed. Three of these data points fell 6t o10mm below the
pontomesencephalic junction, so that here the SEM is also displayed. (C) Representation of the rostrocaudal location of peak
un-normalized alpha power at rest, which correlated strongly in frequency and location with peak alpha power that correlated with gait
(but which required normalization to remove movement artefact thereby also diminishing power gradients). Relative log alpha power is
represented in grey-scale intensity whereby black is highest and white lowest alpha power. Regions relative to the pontomesencephalic
line are numbered as follows: 1, +2 to +6mm; 2, 2 to +2mm; 3, 6t o2mm; 4, 10 to 6mm; and 5, 14 to 10mm. Alpha
power was maximal at location 3 (6t o2mm below the pontomesencephalic line). Beta power was highest in regions 1 and 2
combined. Note: no inference is made regarding location in ventrodorsal or mediolateral planes. DBS = deep brain stimulation; GFQ = Gait
and Falls questionnaire; LFP = local ﬁeld potential; PM = pontomesencephalic line connecting the pontomesencephalic junction to the
caudal end of the inferior colliculi.
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Patient 6 had 24 discrete freezing episodes identiﬁable during
recordings and a local ﬁeld potential alpha peak during gait at
8Hz. Local ﬁeld potential power over 7–9Hz averaged to the
onset of the freezing episodes is represented in Fig. 5. There is
a signiﬁcant associated attenuation in alpha power, which begins
around 1s prior to the onset of freezing and continues for over 2s
thereafter.
Beta band activity
Activity during rest or gait
Beta peaks (mean 21.1Hz, range 17.3–28.5) were relatively focal
to one bipolar contact pair, with normalized peak beta (SEM)
power dropping by 15.4 (2.4)% at the remaining two contact
pairs of each electrode. At rest, the un-normalized peak beta
(SEM) power dropped in the remaining two contact pairs by
45.6 (11.1)%.
Localization
In the six electrodes demonstrating a beta peak (during rest or
gait), normalized beta peak power was signiﬁcantly greater in ros-
tral (higher than 2mm beneath the pontomesencephalic junction)
than caudal contacts [t(16) = 2.232, P=0.040; Fig. 4]. There
were insufﬁcient beta peaks at rest to compare un-normalized
beta peak power with location.
Coherence with EEG
In only one of the six electrodes demonstrating a beta peak, was
there signiﬁcant coherence spanning at least two consecutive 1Hz
bins between the local ﬁeld potential at beta peak frequency and
FzCz.
Relationship with relative gait speed
Normalized beta peak power did not signiﬁcantly correlate with
relative gait speed. Similarly, spectra of correlations between nor-
malized local ﬁeld potential at each frequency and relative gait
speed did not reveal discrete peaks in correlation at the frequen-
cies corresponding to beta peaks.
Therapeutic impact of chronic
stimulation on gait
Therapeutic outcomes from chronic PPN region stimulation are
presented in Table 2. Pre- and postoperative Gait and Falls ques-
tionnaire scores were available in all six cases operated in Oxford,
affording six estimates of therapeutic impact. Gait and Falls ques-
tionnaire scores in these six patients improved withPPN stimula-
tion [mean 42.0–29.8, t(5) = 4.425, P=0.007]. The location
where stimulation was applied along the rostrocaudal axis was
calculated relative to the pontomesencephalic line. Where stimu-
lation was bilateral, stimulation depth was the mean from both
sides. The overall improvement of Gait and Falls questionnaire
scores with PPN stimulation was only moderate. However, closer
examination within this small sample suggests a possible relation-
ship between stimulation depth and percentage improvement in
the Gait and Falls questionnaire with the best outcome being
achieved when stimulation was applied at the level of maximal
alpha activity (Fig. 4B). Thus, a relationship was sought between
power in the alpha band where stimulation was applied and thera-
peutic outcomes. With monopolar stimulation, alpha power was
taken as the mean power recorded from the two ﬂanking bipolar
pairs. A correlation between mean log alpha power at rest and per
cent postoperative Gait and Falls questionnaire improvement con-
ﬁrmed a correspondence between these measures (r = 0.85,
P = 0.033). The picture was similar if the per cent improvement
(20%) in UPDRS II items scoring freezing, falls and gait was
included from the London patient in whom these measures were
used to assess outcome (r = 0.81, P = 0.027).
Discussion
In parkinsonian patients, we found alpha oscillations in a network
involving the caudal subregion of the PPN and the cerebral cortex.
Synchronization of PPN alpha activity in the caudal PPN region
correlated with the performance of gait. Beta oscillations were
found in the rostral PPN subregion but this activity did not correl-
ate with gait.
Figure 5 Change-point analysis of the time series of mean local ﬁeld potential power over 7–9Hz averaged to onset (0 s) of freezing
episodes (n = 24) in Case 6. Horizontal dotted lines are the 95% conﬁdence limit of the whole record and the grey blocks represent stable
periods between changes in power as deﬁned by change-point analysis. There is a signiﬁcant drop in 7–9Hz power 1 s before the onset
of freezing, and 7–9Hz activity continues to be attenuated for just over 2 s thereafter.
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oscillations
A rostrocaudal topographical organization of the PPN is supported
by extensive data from animal research (Martinez-Gonzalez et al.,
2011). Rostral PPN neurons predominantly express -aminobutyric
acid and are strongly interconnected with the basal ganglia includ-
ing subthalamic nucleus and internal pallidum (Mena-Segovia
et al., 2004; Ros et al., 2010; Martinez-Gonzalez et al., 2011),
which exhibit beta activity in untreated Parkinson’s disease
(Hammond et al., 2007). Caudal PPN neurons express predomin-
antly acetylcholine and glutamate (Martinez-Gonzalez et al.,
2011). Cholinergic neurons arborize widely, including to cortex
and locomotor centres (Skinner et al., 1990; Mena-Segovia
et al., 2008). It is therefore congruent that we found beta oscil-
lations in the rostral PPN region and a distinct oscillatory activity in
the caudal PPN region, alpha activity, coherent with cortex and
associated with locomotion. This interpretation is also supported
by the one previous study in which PPN local ﬁeld potentials were
assessed in parkinsonian patients according to recording site depth
(Weinberger et al., 2008). In that study, beta oscillations were
recorded in an area corresponding to what is here deﬁned as
the rostral PPN region. In an example local ﬁeld potential record-
ing, a spectral peak can also be identiﬁed in the alpha band in
what is deﬁned here as the caudal PPN region (1–4mm below the
inferior colliculus). Of further interest, neurons considered by the
authors as likely cholinergic (having long duration action potentials
and low ﬁring rates) were found predominantly in the caudal PPN
region (Weinberger et al., 2008). Such topography could explain
why different centres have reported different dominant oscillatory
patterns, in the alpha or beta frequency bands, from PPN
recordings—as this would be determined by the depth of the im-
planted electrodes (Androulidakis et al., 2008a, b; Weinberger
et al., 2008; Tsang et al., 2010)
The origin of the focal alpha activity in the PPN region needs
consideration. The distribution of electrode contacts in this study
was broad—and this facilitated the relationship between oscillatory
power and location to be recognized. Some contacts lie more
caudal than any described location of the PPN but these were
not the ones expressing alpha at highest power across patients.
Across patients, un-normalized peak alpha power at rest, which
correlated strongly in frequency and location with alpha power
during gait, was maximal between 2mm and 6mm beneath the
pontomesencephalic junction. The spatial accuracy of this ﬁnding
is limited by the bipolar nature of the local ﬁeld potential record-
ings and the averaging of data across patients. However, with this
limitation in mind, a key question is whether this region corres-
ponds to the PPN. The PPN comprises a well-deﬁned ‘pars com-
pacta’ subregion but also a reticular ‘pars dissipata’ with indistinct
boundaries (Olszewski and Baxter, 1954). The atlas of Olszewski
and Baxter (1982) identiﬁes the PPN based on cytoarchitectural
methods. Later, cholinergic PPN neurons were identiﬁed in
humans by immunohistochemical labelling of choline acetyltrans-
ferase (Mesulam et al., 1989; Manaye et al., 1999). Although
these latter studies do not provide stereotactic coordinates, their
relevance has been heightened by the involvement of cholinergic
PPN neurons in gait and its dysfunction (Karachi et al., 2010) and
several observations are of localizing value. While cholinergic PPN
neurons were clustered most densely in the pars compacta, the
pars dissipata accounts for the greater proportion of cholinergic
neurons (Manaye et al., 1999). Cholinergic PPN neurons span at
least 7mm in the rostrocaudal plane being at highest density
2.5mm under the rostral pole (as deﬁned by choline acetyltrans-
ferase staining, so potentially missing any rostral component not
expressing choline acetyltransferase; Manaye et al., 1999).
Cholinergic PPN neurons were noted to lie where the ‘superior
cerebellar peduncle ascends towards the dorsolateral pons towards
its decussation’ with the pars compacta located at the level of
the decussation (Mesulam et al., 1989; Manaye et al., 1999).
Identifying these anatomical landmarks on the axial images of
Patient 3 suggests that the levels 2–4mm below the pontomesen-
cephalic line would therefore correspond to the caudal PPN
region. Other gait related entities also exist in the PPN region
including the cuneiform and subcuneiform nuclei, which together
with the PPN comprise the mesencephalic locomotor region (Alam
et al., 2011). Both the PPN and cuneiform nucleus are activated
during fast imagined gait in functional MRI studies in healthy
Table 2 Pedunculopontine nucleus region stimulation and therapeutic outcomes
Patients Rostrocaudal
stimulation location
(mm to PM line)
Stimulation
settings
(Hz/V/ms)
Preoperative
GFQ (score/64)
Postoperative
GFQ (score/64)
Improvement in
GFQ (%)
Time
post operation
(months)
1 7.65 Bilateral 35/3.5/60 55 38 30.9 2
2 12.7 Unilateral 35/2.3/60 38 34 10.5 13
3
a 5.5 Bilateral 30/2.5/60 36 15 58.3 9
4 1.5 Bilateral 40/1.8/60 49 42 14.3 7
5 8.9 Bilateral 35/2.2/60 36 28 22.2 2
6
b +0.4 Unilateral 30/3.0/60 NA NA NA
b NA
7 7.0 Bilateral 20/2.5/60 38 22 42.1 2
Where bilateral stimulation was applied, voltage reﬂects the mean of both sides.
a Stimulation remains under titration and cycled between off and on, with postoperative GFQ score the best result so far.
b Outcome in this patient was assessed with UPDRS II items scoring freezing, falls and gait with the combined score being 5/16 preoperatively and 4/16 postoperatively (on
medication).
GFQ = Gait and Falls questionnaire; NA = not available; PM = pontomesencephalic.
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suggested that neurons that modulate ﬁring in response to ima-
gined gait actually tend to be located in the subcuneiform region
dorsal to the PPN (Piallat et al., 2009). However, boundaries
between these various nuclei are indistinct—potentially confound-
ing precise determination of the source of neuronal recordings and
of the structures responsible for clinical effects of stimulation in
this region. On the other hand neurons of the PPN, but not the
cuneiform or subcuneiform, are reported to degenerate in associ-
ation with falls in Parkinson’s disease (Karachi et al., 2010).
Furthermore, cytoarchitectural atlases suggest that the cuneiform
and subcuneiform nuclei do not extend as caudally as the zone
where we recorded maximal alpha band activity (Olszewski and
Baxter, 1982).
The distribution of PPN oscillatory activity concurs with previous
work in Parkinson’s disease suggesting that alpha and beta oscil-
latory networks are segregated (Litvak et al., 2010). The function-
al nature of alpha and beta oscillations in Parkinson’s disease also
appears distinct. Beta band activity is pathologically increased in
Parkinson’s disease, is suppressed by L-dopa and high-frequency
subthalamic stimulation and correlates with deﬁcits of bradykinesia
and rigidity (Silberstein et al., 2005; Kuhn et al., 2006; Eusebio
et al., 2010). Alpha power in the PPN tends to increase with L-
dopa, suggesting that it could be pathologically attenuated in
Parkinson’s disease (Androulidakis et al., 2008a, b). It now also
appears that attenuation of PPN alpha activity is associated with
gait freezing whilst increases in PPN alpha power in Parkinson’s
disease correlated with improved gait.
Pedunculopontine nucleus alpha
oscillations and locomotor function
A potential confound needs consideration; that the correlation be-
tween alpha power and gait speed could be due to movement
artefact. Several factors militate against this. First, our local ﬁeld
potential recordings were bipolar, so a signal common across con-
tacts should have been subtracted out. Second, the relative gait
speed correlated maximally with alpha oscillations (7–10Hz),
which differed in frequency from the accelerometer frequencies
used to derive gait speed (1–3Hz). Third, correlation with the
relative gait speed was relatively speciﬁc to alpha local ﬁeld po-
tential activity, evidenced by the peak in correlation spectra at
alpha frequencies and the lack of any correlation with beta
power. Fourth, correlations were present even when local ﬁeld
potential power was normalized to broad band activity, which
effectively eliminated any common artefact from movement.
An important qualiﬁcation is that the correlation between gait
speed and alpha power does not necessarily imply causation and
the relationship could be epiphenomenal. For example, alpha
power may be permissive for higher gait speeds or reactive to it.
However, correlations were found within a brain area that is func-
tionally relevant to gait disturbance, as evidenced by the potential
for improvement upon PPN stimulation. Furthermore, the positive
nature of the correlation between alpha synchronization and
increasing gait speed, concurs with the synchronization of alpha
power observed with L-dopa (Androulidakis et al., 2008a, b),
which also tends to improve gait. Yet, even if PPN alpha oscilla-
tions are mechanistically important in gait disturbance, the rela-
tionship does not appear obligatory or exclusive. The mean
correlation was 0.43, so that ﬂuctuations in alpha power only
predicted 20% (r
2 = 0.19) of the variance in relative gait
speed. A further question is whether this alpha activity also relates
speciﬁcally to gait freezing. Due to the reduction in freezing post-
operatively due to a possible stun effect, we could only compare
freezing episodes with alpha power in a single patient, who was
implanted unilaterally. This demonstrated an attenuation of alpha
activity related to the onset of freezing. This suggests that higher
gait speeds could have, at least partly, resulted from relief of
freezing related deﬁcits even if discrete freezing episodes did not
frequently occur. For example, patients with gait freezing are re-
ported to have continuous background deﬁcits in gait, including
reduced gait velocity, step length and increased spatiotemporal
variability (Hausdorff et al., 2003b; Chee et al., 2009; Snijders
et al., 2011). It is notable that attenuation of alpha local ﬁeld
potential power preceded freezing onset. However, this latter ﬁnd-
ing should be interpreted cautiously given the limited accuracy in
determining when exactly freezing begins.
Thus, a particular limitation of the current study was the limited
characterization of gait performance in terms of relative gait speed
and the analysis of freezing in only one patient. Gait dysfunction
in Parkinson’s disease is complex, with varying involvement of
features such as gait initiation, turning, postural instability and
gait velocity (Bloem, 1992; Morris et al., 1994; Hausdorff et al.,
2003b; Sofuwa et al., 2005). The failure to capture these features
might also help explain why ﬂuctuations in alpha power only pre-
dicted 20% of the variance in relative gait speed.
By what mechanism could PPN alpha activity relate to gait per-
formance, as indexed by relative gait speed? Gait speed reduces in
healthy subjects, elderly fallers and in Parkinson’s disease during
the performance of a second, unrelated task (‘dual tasking’)
(Hausdorff et al., 2003a; Springer et al., 2006; Lamoth et al.,
2011). In elderly subjects, an inability to ‘walk whilst talking’ pre-
dicts falls (Lundin-Olsson et al., 1997). Such ﬁndings implicate
‘attention’ and the effective allocation of processing resources
that ﬂows from it, as a potentially important factor inﬂuencing
gait speed. In Parkinson’s disease, attentional deﬁcits are
common and there is also impaired automaticity of movement
so that processing demands are higher (Wu and Hallett, 2005,
2008). Parkinsonian patients with gait freezing are reported to
have even more attentional deﬁcits than those without gait
freezing (Amboni et al., 2008; Yogev-Seligmann et al., 2008).
Dual tasking can worsen gait freezing, as can other precipitants
that are thought to ‘distract’ attention away from gait (Giladi and
Hausdorff, 2006).
There is increasing evidence that alpha activity has an important
role in attention and the allocation of processing resources. The
synchronization of occipital alpha with eye closure was once in-
terpreted to reﬂect passive ‘idling’ (Berger, 1929; Pfurtscheller
et al., 1996). However, alpha activity is now considered to support
active suppression of task irrelevant processes (Jensen and
Mazaheri, 2010). For example, during working memory tasks, cor-
tical alpha power in visual and motor–sensory areas increases and
the degree of synchronization correlates with the number of items
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performance with oscillatory power in task irrelevant regions sug-
gests suppression rather than mere idling. It has been proposed
that within the motor system, suppression of competing processes
with alpha could aid the smooth execution of motor programmes
(Pfurtscheller and Neuper, 1994; Suffczynski et al., 2001). Regions
such as the subthalamic nucleus and caudal PPN that have dis-
tributed functional connectivity, including with cerebral cortical
areas, would be placed to operationalize this putative role. Thus
PPN deep brain stimulation is able to increase blood ﬂow in an
extensive network of subcortical and cortical areas involved in
balance and motor control (Strafella et al., 2008; Ballanger
et al., 2009).
Clinical relevance to pedunculopontine
nucleus stimulation
Gait freezing improved following electrode implantation in the ab-
sence of any stimulation in all patients, although this was less
pronounced in patients implanted unilaterally. Gait freezing is no-
torious for improving during medical assessments, perhaps due to
attentional or placebo effects. However, we observed that the
improvement in gait freezing persisted for up to 6 weeks
post-implantation—a time course arguably more consistent with
a stun effect. In the subthalamic nucleus, the ‘stun’ or ‘microle-
sion’ effect of surgery is usually attributed to suppression of beta
activity in the target nucleus by acute tissue disruption from elec-
trode implantation (Chen et al., 2006; Koop et al., 2006).
However, in the caudal PPN, alpha activity persisted despite the
apparent stun effect and correlated positively with gait perform-
ance. Accordingly, we speculate that stun effects in PPN surgery
might predominately arise from microlesioning inhibitory suprasp-
inal inﬂuences along the electrode trajectory. Excessive inhibition
of the PPN (for example from the internal pallidum) has been
considered a pathophysiological factor causing gait and postural
disturbance in Parkinson’s disease, in addition to PPN neuronal
degeneration (Aziz et al., 1998). Consistent with this reasoning,
in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
primate model of Parkinson’s disease, the microinjection of a
-aminobutyric acid antagonist into the PPN improved mobility
(Nandi et al., 2002). Microlesioning inhibitory afferents to the
PPN would be expected to have analogous effects. If this reason-
ing is correct, then the occurrence of a possible stun effect would
not necessarily indicate accurate electrode placement within the
PPN, nor necessarily portend beneﬁt from stimulation.
The topographic arrangement of oscillations in the PPN region
along the rostrocaudal axis raises the possibility that caudal and
rostral PPN stimulation could have different therapeutic effects.
Alpha and beta oscillatory activity could provide functional bio-
markers for these different subregions. Alpha and beta activity in
the PPN region were focal, evidenced by un-normalized oscillatory
power at rest dropping by an average of 42% for alpha activity
and 45% for beta activity across bipolar recording sites. This is
similar to the gradients of beta activity reported across the dorso-
lateral subthalamic nucleus that can be detected in intraoperative
and postoperative recordings and used to guide deep brain stimu-
lation electrode implantation (Chen et al., 2006).
Only the alpha activity recorded in the caudal PPN region was
demonstrated to be functionally related to gait and gait freezing.
Therapeutic outcomes from PPN region stimulation were variable
between patients as were the locations along the rostrocaudal axis
where stimulation was applied. Interestingly, the best outcome
was achieved when stimulation was applied at the level of max-
imal alpha activity, 2–6mm below the pontomesencephalic junc-
tion, so that per cent improvement in Gait and Falls questionnaire
score at different depths closely correlated with the alpha power
recorded at the same depths. We take this to be an encouraging
preliminary ﬁnding, noting that patient numbers were small, uni-
lateral and bilateral stimulation were mixed, postoperative periods
were relatively short and our outcome measure was not objective.
Accordingly, it is important that future studies examine whether
the efﬁcacy of PPN stimulation relates to stimulation location
‘within’ patients, preferably using objective gait measures. Still,
the current study is important in providing physiological evidence,
supported by consistent clinical ﬁndings, that the site of stimula-
tion along the rostrocaudal axis of the PPN region might be a
factor determining therapeutic outcomes.
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